Has Shatha Yousef received payments from drug or device companies?

Yes. Drug and device makers reported $5,007 in general payments to Shatha Yousef across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shatha Yousef did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shatha Yousef come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shatha Yousef

Pediatric Pulmonology · Orlando, FLNPI 1902099658

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Mylan Specialty L.p. at 52.6% of the total. Reporting peaked in 2021 at $2,659 and has fallen 95.0% since, to $133 in 2023.

$5,007in general payments, 2019–2025

Across 65 payments — averaging $77.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Mylan Specialty L.p.$3K
Boehringer Ingelheim$805
Gilead$385
Philips North America LLC$340
Chiesi USA, Inc.$274
Octapharma USA, Inc.$121
plus $449 from 10 others

$156,478in research payments, 2019–2025

Across 42 payments — averaging $3725.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vertex$74K
Boehringer Ingelheim$72K
Mylan Inc.$6K
Boehringer Ingelheim France S.a.s.$4K
Boehringer Ingelheim International GmbH$895

What the payments were for

Consulting fees$2,50050%
Travel & lodging$62512%
Food & beverage$1,85837%
Education$240%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Mylan Specialty L.p.	4	$2,634
Boehringer Ingelheim	6	$805
Gilead	9	$385
Philips North America LLC	15	$340
Chiesi USA, Inc.	11	$274
Octapharma USA, Inc.	1	$121
Regeneron Healthcare Solutions, Inc.	1	$106
GSK	5	$80
Alcresta Therapeutics, Inc.	3	$60
AbbVie	2	$39
Nestle Healthcare Nutrition Inc.	1	$39
Jazz Pharmaceuticals Inc.	2	$34
AstraZeneca	2	$31
Vertex	1	$26
Advanced Respiratory, Inc	1	$20
Sanofi	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,007 in reported general payments places this provider in the 80th percentile of 72 pediatric pulmonology providers in Florida.

See all pediatric pulmonology providers in Florida →

Other pediatric pulmonology in Orlando

Floyd LivingstonOrlando$110K
Aledie NavasOrlando$29K
Daniel GarciaOrlando$9K
Shilpa PandeyOrlando$3K
Tarig Ali-DinarOrlando$2K
Mohammed Al-HumiariOrlando$2K
Carlos SabogalOrlando$1K
Luis FaverioOrlando$763
Christie CherianOrlando$696
Maggie SifainOrlando$581

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →